T2 Biosystems Inc. (TTOO)

1.64
NASDAQ : Health Technology
Prev Close 1.66
Day Low/High 1.61 / 1.72
52 Wk Low/High 1.35 / 7.70
Avg Volume 798.30K
Exchange NASDAQ
Shares Outstanding 44.34M
Market Cap 73.60M
EPS -1.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Small Biotechs Finally Join in Market Rebound

Small Biotechs Finally Join in Market Rebound

Exelixis Inc. and Aratana Therapeutics in particular surge after posting solid results Thursday.

2 Stocks I'm Buying This Week as Investors Flee Small-Cap Biotechs

2 Stocks I'm Buying This Week as Investors Flee Small-Cap Biotechs

This is why I always have some 'dry powder' to deploy during these temporary hiccups.

Consider These Diagnostic Testing Firms

Consider These Diagnostic Testing Firms

Diagnostic firms can have an advantage of recurring revenue streams.

3 Small Biotechs Turn on the Revenue Jets

3 Small Biotechs Turn on the Revenue Jets

BioDelivery Sciences, Neos Therapeutics and Invitae Corp. are delivering big increases in sales.

How to Play Biotech 'Sell the News' Pattern

How to Play Biotech 'Sell the News' Pattern

Patient investors can profit from small-cap biotech stocks that often slide once positive news comes out.

3 Busted IPOs with 10-Bagger Potential

3 Busted IPOs with 10-Bagger Potential

Verastem Inc., T2 Biosystems Inc. and Resonant Inc. have great long-term growth prospects.

How to Manage Risk in Biotech Stocks

How to Manage Risk in Biotech Stocks

T2 Biosystems' recent run-up on a positive event provides an important lesson for biotech investors.

Two Antibiotic Plays

Two Antibiotic Plays

They may not get all the attention, but antibiotic drugs are increasingly important.

How to Manage Risk in Biotech

How to Manage Risk in Biotech

T2 Biosystems used the run-up on a positive event - an FDA approval - to raise additional capital.

3 of My Favorite Medical Diagnostic Plays

3 of My Favorite Medical Diagnostic Plays

These equities have been in rally mode since April.

Three Stocks on the Move

Markets off to a decent start to the trading day with all the major indices up a half hour into trading. Some of the names I have profiled in recent months are on the move early today. Let's take a look at a few of these: T2 Biosystems after posting...

3 Promising Biotech Stocks to Buy on Dips

3 Promising Biotech Stocks to Buy on Dips

From ANI Pharmaceuticals to T2 Biosystems, these names look good.

Three Biotech Opportunities

Three Biotech Opportunities

Celgene, ANI and T2 are seeing attractive entry points.

Biotech Shows Strength

The major indices have improved a tad since our last update. Biotech has shown some strength over the past two hours or so. There are two names to keep an eye on: T2 Biosystems  has been strong so far in 2018, moving from around $4 to over $5 a shar...

Could These 2 Biotech 'Busted IPOs' Be the Next Ignyta?

Could These 2 Biotech 'Busted IPOs' Be the Next Ignyta?

After Roche's acquisition of Ignyta, I have high hopes for these other two names in 2018.

2 Biotech 'Busted IPOs' to Watch in 2018

2 Biotech 'Busted IPOs' to Watch in 2018

Are these names the next 'Ignytas'?

The Best Part of the Biotech Rally This Year Is Probably Over

The Best Part of the Biotech Rally This Year Is Probably Over

The Nasdaq Biotech Index is up 25% so far this year

Biotech Mailbag: Buy Dip in T2 Biosystems?

Biotech Mailbag: Buy Dip in T2 Biosystems?

Plus, what's going on with Lexicon Pharmaceuticals?

2 Small Biotechs Under $5 May Be Bargains

2 Small Biotechs Under $5 May Be Bargains

T2 Biosystems and Synergy Pharmaceuticals offer promising prospects at reasonable prices.

Rally Likely To Be Short-Lived

Rally Likely To Be Short-Lived

The charts indicate more weakness is on the way.